Novo Nordisk

Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. For more information, visit novonordisk.com.

Novo Nordisk strives to conduct its activities in a financially, environmentally and socially responsible way. The strategic commitment to corporate sustainability has brought the company onto centre stage as a leading player in today’s business environment, recognised for its integrated reporting, stakeholder engagement and consistently high sustainability performance. In 2013, Novo Nordisk received the Pharmaceuticals and Biotechnology industry group top ranking on Corporate Knight’s list of Global 100 Most Sustainable Corporations. For more information, visit novonordisk.com/sustainability.

Health & Healthcare | Novo Nordisk

How Do We Innovate Diabetes Care in Africa’s Biggest Country?

Sep 29, 2016 10:00 AM ET

Like many other countries in the region, Algeria is facing the growing health challenge of non-communicable diseases (NCDs). In fact, more than three-quarters of deaths in Algeria today are related to NCDs, including diabetes.

Videos

Health & Healthcare | Novo Nordisk

Fast Food has Replaced Everything

Apr 1, 2016 9:15 AM ET

Cities influence how we live, travel and eat, all of which have an impact on our health. Novo Nordisk’s latest issue of TBL Quarterly takes you to the city streets to show the challenges and opportunities to improve the health of urbanites living with type 2 diabetes. ​

Health & Healthcare | Novo Nordisk

Leading Lights: Global Trailer

Nov 13, 2015 10:00 AM ET

Awards, Ratings & Rankings | Novo Nordisk

Novo Nordisk Remains in Top of 2015 Dow Jones Sustainability World Index

Sep 10, 2015 3:00 PM ET

Novo Nordisk stays in top of the pharmaceutical sector on the 2015 Dow Jones Sustainability World Index with a score of 81 out of a possible 100. The company’s overall score falls 3 points from 2014 and is 7 points behind Roche, the 2015 industry leader.

Health & Healthcare | Novo Nordisk

Three Bottom Lines - One Mindset

Aug 14, 2015 1:00 PM ET

Health & Healthcare | Novo Nordisk

Novo Nordisk Case Study Shows Path to Lowering Costs and Improving Diabetes Care in Turkey

Nov 26, 2014 10:00 AM ET